期刊文献+

溶骨症发病机制的研究进展 被引量:1

Research Progress in Pathogenesis of Osteolytic Disease
下载PDF
导出
摘要 溶骨症又称为Gorham综合征,是一种病因不明,主要侵犯骨骼罕见的综合征,主要临床表现为慢性自发性骨溶解,并可因此引发一系列临床症状。病理改变主要为脉管异常增殖和骨溶解两方面。前者可因非瘤性毛细血管和淋巴管异常增殖所致,后者系破骨细胞数目增多和活性增强或成骨细胞退行性改变。两者之间可能存在某种内在联系而导致互相促进。迄今为止,国内外报道共200余例,但大多数报道针对该病的诊断及临床疗效,而缺乏对该病发病机制的陈述。 Osteolytic disease,also known as Gorham syndrome,is a rare syndrome of unknown etiology that mainly invades bones.The main clinical manifestation is chronic spontaneous osteolysis,which can lead to a series of clinical symptoms.Pathological changes are mainly abnormal vascular proliferation and osteolysis.The former can be caused by abnormal proliferation of the capillaries and lymphatic vessels;the latter is due to the increased number and activity of osteoclasts or degenerative changes of osteoblasts.There may be an intrinsic link between the two,which leads to mutual promotion.Up to now,more than 200 cases have been reported in domestic and foreign literature,however,most of them were aimed at the diagnosis and clinical efficacy of the disease,while the statements about the pathogenesis are still in lack.
作者 李涛 刘屿 许彪 LI Tao;LIU Yu;XU Biao(Department of Oral and Maxillofacial Surgery,Affiliated Stomatology Hospital of Kunming Medical University,Kunming 650106,China)
出处 《医学综述》 2018年第8期1504-1508,共5页 Medical Recapitulate
基金 口腔疾病研究国家重点实验室开放课题(SKLOD2015OF10) 云南省卫生科技计划项目(2016NS115) 云南省教育厅科学研究基金(2016ZDX064)
关键词 溶骨症 发病机制 脉管增殖 骨溶解 Osteolytic disease Pathogenesis Vessel hyperplasia Osteolysis
  • 相关文献

参考文献2

二级参考文献42

  • 1Aviv, R., McHugh, K., Hunt, J., 2001. Angiomatosis of bone and soft tissue: a spectrum of disease from diffuse lymphangiomatosis to vanishing bone disease in young patients. Clin. Radiol., 56(3):184-190. [doi:10.1053/crad. 2000.0606].
  • 2Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A., Marme, D., 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-L Blood, 87(8): 3336-3343.
  • 3Boyer, P., Bourgeois, P., Boyer, 0., Catonne, Y., Saillant, G., 2005. Massive Gorham-Stout syndrome of the pelvis. Clin. Rheumatol., 24(5):551-555. [doi:10.1007/s10067- 005-1088-7].
  • 4Browne, I.A., Shives, T.C., Trousdale, R.T., 2011. Thirty-year follow-up of patient with Gorham disease (massive osteolysis) treated with hip arthroplasty. J. Arthropl., 26(2):339.e7-339.e 1 O. [doi:1 0.1 016/j.arth.201 0.03.003].
  • 5Bruch-Gerharz, D., Gerharz, C.D., Stege, H., Krutmann, J., Pohl, M., Koester, R., Ruzicka, T., 2007. Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: A novel clue to the pathogenesis of a rare syndrome. J. Am. Acad. Dermatol., 56(2): S21-S25. [doi: 1 0.1 016/j.jaad.2006.01.063].
  • 6Choma, N.D., Biscotti, C.V., Bauer, T.W., Mehta, A.C., Licata, A.A., 1987. Benign diseases syndrome: a case report and review of the literature. Am. J. Med., 83(6): 1151-1156.
  • 7Collins, J., 2006. Case 92: Gorham syndromel. Radiology, 238(3): 1 066. [doi:10.1148/radioI.2383032126].
  • 8Deveci, M., Inan, N., Corapcioglu, F., Ekingen, G., 2011. Gorham-Stout syndrome with chylothorax in a six-yearold boy. Ind. J. Pediatr., 78(6):737-739. [doi:10.10071 512098-010-0328-2].
  • 9Devlin, R.D., Bone, H.G.3rd, Roodman, G.D., 1996. Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J. Clin. Endocrinol. Metabol., 81(5):1893-1897. [doi:10.1210/jc. 81.5.1893].
  • 10Dunbar, S.F., Rosenberg, A., Mankin, H., Rosenthal, D., Suit, H.D., 1993. Gorham's massive osteolysis: the role of radiation therapy and a review of the literature. Int. J. Rad. Oncol. Bioi. Phys., 26(3):491-497. [doi:10.1016/0360- 3016(93)90968-2].

共引文献15

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部